The cost of drug coupons

JAMA

Volumn 307, Issue 22, 2012, Pages 2375-2376

  Grande, David ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GENERIC DRUG; ROSUVASTATIN; SIMVASTATIN; DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG PROGRAM; HEALTH INSURANCE; HUMAN; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROGRAM DEVELOPMENT; SHORT SURVEY; ARTICLE; CHRONIC DISEASE; COST; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; INSURANCE; MEDICARE; PATIENT COMPLIANCE; PHARMACY; STATISTICS; UNITED STATES;

CHRONIC DISEASE; COST SHARING; DRUG COSTS; DRUG INDUSTRY; FINANCING, PERSONAL; HEALTH CARE COSTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSURANCE COVERAGE; MEDICARE PART D; MEDICATION ADHERENCE; PHARMACEUTICAL PREPARATIONS; PHARMACIES; UNITED STATES;

EID: 84862251073     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.5603     Document Type: Short Survey

References (7)

1. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42(7):626-634.
2. Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010;48(2):87-94.
3. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299(16):1922-1928. (Pubitemid 351574922)
4. Pharmaceutical Care Management Association. How copay coupons could raise prescription drug costs by $32 billion over the next decade. Pharmaceutical Care Management Association website. http://www.pcmanet.org/ images/stories/uploads/2011/Nov2011/visante%20copay%20coupon%20study.pdf. November 2011. Accessed April 17, 2012.
5. Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM. Generic atorvastatin and health care costs. N Engl J Med. 2012;366(3):201-204.
6. Lipkus IM, Samsa G, Rimer BK. General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001;21(1):37-44. (Pubitemid 32245029)
7. Thomas JM, Wasserstein JN. His name was RICO, he wore a diamond: lawsuits allege that coupons and savings programs for brand-name drugs violate RICO, antitrust law. FDA Law Blog website. http://www.fdalawblog.net/fda-law-blog- hyman-phelps/2012/03/his-name-was-rico-he-wore-a-diamond-lawsuits-allege-that- coupons-and-savings-programs-for-brand-name.html. 2012. Accessed April 17, 2012.